Pharming Group N.V. Files 6-K with June Press Release
Ticker: PHAR · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1828316
| Field | Detail |
|---|---|
| Company | Pharming Group N.V. (PHAR) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, press-release, foreign-private-issuer
TL;DR
Pharming Group N.V. dropped a 6-K on June 11th with a press release attached - check Exhibit 99.1.
AI Summary
Pharming Group N.V. filed a Form 6-K on June 11, 2025, to furnish a press release dated the same day. The filing is for the month of June 2025 and indicates that the company files annual reports under Form 20-F. The press release itself is included as Exhibit 99.1.
Why It Matters
This filing provides investors with timely information, specifically a press release, from Pharming Group N.V. as required for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) to furnish a press release, not indicating any new material events or financial distress.
Key Players & Entities
- Pharming Group N.V. (company) — Registrant
- June 11, 2025 (date) — Filing and Press Release Date
- 001-39822 (other) — Commission File Number
- Exhibit 99.1 (document) — Attached Press Release
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to furnish a press release dated June 11, 2025, as required for foreign private issuers.
What is the Commission File Number for Pharming Group N.V.?
The Commission File Number for Pharming Group N.V. is 001-39822.
Which exhibit contains the press release?
The press release is furnished as Exhibit 99.1 to this Report on Form 6-K.
Does Pharming Group N.V. file annual reports under Form 20-F or 40-F?
Pharming Group N.V. files annual reports under cover of Form 20-F.
What is the principal executive office address of Pharming Group N.V.?
The principal executive offices are located at Darwinweg 24, 2333 CR Leiden, The Netherlands.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding Pharming Group N.V. (PHAR).